does glp 1 cause breast cancer GLP-1 Use Linked to Lower Incidence in One Study Semaglutide decelerates the growth and
Description
Spder P, Liu J, Brand AH

The FDA is unequivocal that "retatrutide and cagrilintide cannot be used in compounding under federal law." "These are not components of FDA-approved drugs and have not been found safe and effective for any condition," the agency said in drug safety information posted online

Additionally, lean individuals have reported more side effects compared to overweight individuals when treated with GLP-1R agonists

While these medicines are generally safe, many people have reported some side effects 1 , especially during the early stages of treatment 2
